A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558

Name: A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558
Published: 2023
License: Public Domain

Aligos Therapeutics · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

covid-19, healthy volunteer, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558

Related documents